Article
The impact of IL-10 and CYP3A5 gene polymorphisms on dose-adjusted trough blood tacrolimus concentrations in early post-renal transplant recipients.
Pharmacological reports : PR - 1 Oct 2021
Chen Zhaolin, Cheng Xi, Zhang Liwen, Tang Liqin, Fang Yan, Chen Hongxiao, Zhang Lei, Shen Aizong
Abstract excerpt
BACKGROUND: The strong inter-individual pharmacokinetic variability and the narrow therapeutic window of tacrolimus (TAC) have hampered the clinical application. Gene polymorphisms play an important role in TAC pharmacokinetics. Here, we investigate the influence of genotypes of IL-10, CYP3A5, CYP2C8, and ABCB1 on dose-adjusted trough blood concentrations (the C0/D ratio) of TAC to reveal unclear genetic factors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
